GB9912476D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB9912476D0
GB9912476D0 GBGB9912476.0A GB9912476A GB9912476D0 GB 9912476 D0 GB9912476 D0 GB 9912476D0 GB 9912476 A GB9912476 A GB 9912476A GB 9912476 D0 GB9912476 D0 GB 9912476D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
cyclosporin
carrier medium
provides composition
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9912476.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB9912476.0A priority Critical patent/GB9912476D0/en
Publication of GB9912476D0 publication Critical patent/GB9912476D0/en
Priority to US09/579,372 priority patent/US6432445B1/en
Priority to BR0011030-2A priority patent/BR0011030A/pt
Priority to AU58100/00A priority patent/AU765935B2/en
Priority to HU0201372A priority patent/HUP0201372A3/hu
Priority to SK1722-2001A priority patent/SK285471B6/sk
Priority to CA002371247A priority patent/CA2371247A1/en
Priority to PCT/EP2000/004829 priority patent/WO2000072867A2/en
Priority to RU2001133455/15A priority patent/RU2249461C2/ru
Priority to DE10084671T priority patent/DE10084671T1/de
Priority to DK00943742T priority patent/DK1181035T3/da
Priority to HK02105374.3A priority patent/HK1045642B/en
Priority to IL14618600A priority patent/IL146186A0/xx
Priority to MXPA01012222A priority patent/MXPA01012222A/es
Priority to EP00943742A priority patent/EP1181035B1/en
Priority to DE60019100T priority patent/DE60019100T2/de
Priority to SI200030699T priority patent/SI1181035T1/xx
Priority to AT00943742T priority patent/ATE291926T1/de
Priority to PL351593A priority patent/PL199591B1/pl
Priority to KR1020017013293A priority patent/KR20010111587A/ko
Priority to ES00943742T priority patent/ES2239605T3/es
Priority to PT00943742T priority patent/PT1181035E/pt
Priority to TR2001/03276T priority patent/TR200103276T2/xx
Priority to GB0128277A priority patent/GB2367004B/en
Priority to CZ20014214A priority patent/CZ20014214A3/cs
Priority to DE20022951U priority patent/DE20022951U1/de
Priority to JP2000620976A priority patent/JP2003500454A/ja
Priority to NZ515154A priority patent/NZ515154A/en
Priority to CN00808183A priority patent/CN1353613A/zh
Priority to ZA200109658A priority patent/ZA200109658B/xx
Priority to NO20015785A priority patent/NO20015785L/no
Priority to US10/217,732 priority patent/US6767555B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Surgery (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fats And Perfumes (AREA)
GBGB9912476.0A 1999-05-28 1999-05-28 Organic compounds Ceased GB9912476D0 (en)

Priority Applications (32)

Application Number Priority Date Filing Date Title
GBGB9912476.0A GB9912476D0 (en) 1999-05-28 1999-05-28 Organic compounds
CN00808183A CN1353613A (zh) 1999-05-28 2000-05-26 药物组合物
EP00943742A EP1181035B1 (en) 1999-05-28 2000-05-26 Substantially oil-free cyclosporin compositions
DE60019100T DE60019100T2 (de) 1999-05-28 2000-05-26 Im wesentlichen ölfreie cyclosporin zusammensetzungen
AU58100/00A AU765935B2 (en) 1999-05-28 2000-05-26 Substantially oil-free cyclosporin compositions
HU0201372A HUP0201372A3 (en) 1999-05-28 2000-05-26 Pharmaceutical compositions comprising cyclosporin
SK1722-2001A SK285471B6 (sk) 1999-05-28 2000-05-26 Farmaceutické prostriedky obsahujúce cyklosporín
CA002371247A CA2371247A1 (en) 1999-05-28 2000-05-26 Substantially oil-free cyclosporin compositions
PCT/EP2000/004829 WO2000072867A2 (en) 1999-05-28 2000-05-26 Substantially oil-free cyclosporin compositions
RU2001133455/15A RU2249461C2 (ru) 1999-05-28 2000-05-26 Включающие циклоспорин композиции, практически не содержащие масла
AT00943742T ATE291926T1 (de) 1999-05-28 2000-05-26 Im wesentlichen ölfreie cyclosporin zusammensetzungen
DK00943742T DK1181035T3 (da) 1999-05-28 2000-05-26 Praktisk taget oliefri cyclosporinpræparater
HK02105374.3A HK1045642B (en) 1999-05-28 2000-05-26 Basically oil-free CYCLOSPORIN composition
IL14618600A IL146186A0 (en) 1999-05-28 2000-05-26 Substantially oil-free cyclosporin compositions
MXPA01012222A MXPA01012222A (es) 1999-05-28 2000-05-26 Composiciones de ciclosporina susbtancialmente libres de aceite.
US09/579,372 US6432445B1 (en) 1999-05-28 2000-05-26 Pharmaceutical capsules comprising a cyclosporin
SI200030699T SI1181035T1 (en) 1999-05-28 2000-05-26 Substantially oil-free cyclosporin compositions
PL351593A PL199591B1 (pl) 1999-05-28 2000-05-26 Kompozycja w postaci kapsułki, zawierająca cyklosporynę, zastosowanie kompozycji zawierajacej cyklosporynę oraz sposób otrzymywania takiej kompozycji
DE10084671T DE10084671T1 (de) 1999-05-28 2000-05-26 Pharmazeutische Zusammensetzungen
BR0011030-2A BR0011030A (pt) 1999-05-28 2000-05-26 Composições de cicloporina substancialmente livre de óleo
KR1020017013293A KR20010111587A (ko) 1999-05-28 2000-05-26 약제학적 조성물
ES00943742T ES2239605T3 (es) 1999-05-28 2000-05-26 Composiciones de ciclosporina substancialmente libres de aceites.
PT00943742T PT1181035E (pt) 1999-05-28 2000-05-26 Composicoes de ciclosporina substancialmente isentas de oleo
TR2001/03276T TR200103276T2 (tr) 1999-05-28 2000-05-26 Yeterince yağsız siklosporin kompozisyonları
GB0128277A GB2367004B (en) 1999-05-28 2000-05-26 A cyclosporin containing composition in the form of a capsule
CZ20014214A CZ20014214A3 (cs) 1999-05-28 2000-05-26 Cyklosporinové prostředky v podstatě prosté oleje
DE20022951U DE20022951U1 (de) 1999-05-28 2000-05-26 Pharmazeutische Zusammensetzungen
JP2000620976A JP2003500454A (ja) 1999-05-28 2000-05-26 実質的にオイルフリーのシクロスポリン組成物
NZ515154A NZ515154A (en) 1999-05-28 2000-05-26 Cyclosporin in a capsule comprising a polyoxyethylene sorbitan and sorbitan fatty acid esters, a reaction product of caster oil and ethylene oxide and ethanol
ZA200109658A ZA200109658B (en) 1999-05-28 2001-11-23 Substantially oil-free cyclosporin compositions.
NO20015785A NO20015785L (no) 1999-05-28 2001-11-27 I dets vesentlige oljefrie cyklosporinblandinger
US10/217,732 US6767555B2 (en) 1999-05-28 2002-08-13 Pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9912476.0A GB9912476D0 (en) 1999-05-28 1999-05-28 Organic compounds

Publications (1)

Publication Number Publication Date
GB9912476D0 true GB9912476D0 (en) 1999-07-28

Family

ID=10854362

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9912476.0A Ceased GB9912476D0 (en) 1999-05-28 1999-05-28 Organic compounds
GB0128277A Expired - Fee Related GB2367004B (en) 1999-05-28 2000-05-26 A cyclosporin containing composition in the form of a capsule

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0128277A Expired - Fee Related GB2367004B (en) 1999-05-28 2000-05-26 A cyclosporin containing composition in the form of a capsule

Country Status (26)

Country Link
US (2) US6432445B1 (cg-RX-API-DMAC7.html)
EP (1) EP1181035B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003500454A (cg-RX-API-DMAC7.html)
KR (1) KR20010111587A (cg-RX-API-DMAC7.html)
CN (1) CN1353613A (cg-RX-API-DMAC7.html)
AT (1) ATE291926T1 (cg-RX-API-DMAC7.html)
AU (1) AU765935B2 (cg-RX-API-DMAC7.html)
BR (1) BR0011030A (cg-RX-API-DMAC7.html)
CA (1) CA2371247A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20014214A3 (cg-RX-API-DMAC7.html)
DE (2) DE10084671T1 (cg-RX-API-DMAC7.html)
ES (1) ES2239605T3 (cg-RX-API-DMAC7.html)
GB (2) GB9912476D0 (cg-RX-API-DMAC7.html)
HK (1) HK1045642B (cg-RX-API-DMAC7.html)
HU (1) HUP0201372A3 (cg-RX-API-DMAC7.html)
IL (1) IL146186A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA01012222A (cg-RX-API-DMAC7.html)
NO (1) NO20015785L (cg-RX-API-DMAC7.html)
NZ (1) NZ515154A (cg-RX-API-DMAC7.html)
PL (1) PL199591B1 (cg-RX-API-DMAC7.html)
PT (1) PT1181035E (cg-RX-API-DMAC7.html)
RU (1) RU2249461C2 (cg-RX-API-DMAC7.html)
SK (1) SK285471B6 (cg-RX-API-DMAC7.html)
TR (1) TR200103276T2 (cg-RX-API-DMAC7.html)
WO (1) WO2000072867A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200109658B (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK285019B6 (sk) * 1997-01-30 2006-04-06 Novartis Ag Tvrdá želatínová tobolka
ATE404172T1 (de) 1998-12-30 2008-08-15 Dexcel Ltd Dispergierbares konzentrat zur verabreichung von cyclosporin
GB9912476D0 (en) * 1999-05-28 1999-07-28 Novartis Ag Organic compounds
AR033711A1 (es) * 2001-05-09 2004-01-07 Novartis Ag Composiciones farmaceuticas
CA2471241A1 (en) * 2001-12-20 2003-07-03 Bernard Charles Sherman Pharmaceutical compositions comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
US7538084B2 (en) * 2003-03-17 2009-05-26 Amr Technology, Inc. Cyclosporins
JP2005255677A (ja) * 2004-02-12 2005-09-22 Nof Corp シクロスポリン製剤
US20060014677A1 (en) * 2004-07-19 2006-01-19 Isotechnika International Inc. Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds
JP2008514701A (ja) * 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド シクロスポリンアルキン類似体およびそれらの薬学的使用
JP2008514702A (ja) * 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド 新規シクロスポリン類似体およびそれらの薬学的使用
JP2008515886A (ja) * 2004-10-06 2008-05-15 エーエムアール テクノロジー インコーポレイテッド シクロスポリンアルキンおよびそれらの医用薬剤としての有用性
AU2006235478B2 (en) * 2005-04-12 2011-07-21 Elan Pharma International Limited Nanoparticulate and controlled release compositions comprising cyclosporine
WO2006114776A1 (en) * 2005-04-27 2006-11-02 Kingspan Holdings (Irl) Limited Surfactant for phenolic foam
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
MY158809A (en) * 2010-09-22 2016-11-15 Craun Res Sdn Bhd Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
WO2020018974A1 (en) 2018-07-20 2020-01-23 Lipocine Inc. Liver disease

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7012460A (cg-RX-API-DMAC7.html) 1970-08-22 1972-02-24
DE3225706C2 (de) 1982-07-09 1984-04-26 A. Nattermann & Cie GmbH, 5000 Köln Flüssige Wirkstofformulierungen in Form von Konzentraten für Mikroemulsionen
DE3315805A1 (de) 1983-04-30 1984-11-08 Bayer Ag, 5090 Leverkusen Wirkstoffzubereitungen
GB8903804D0 (en) 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
FR2609631A1 (fr) 1987-01-15 1988-07-22 Sanofi Sa Compositions liquides stables a base de bithionol
US6007840A (en) 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5342625A (en) 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
DE3908047A1 (de) 1989-03-13 1990-09-20 Desitin Arzneimittel Gmbh Hochdisperse pharmazeutische zusammensetzung
US5389688A (en) 1989-12-11 1995-02-14 Isp Investments Inc. Water based microemulsion formulations
US5283229A (en) 1989-12-11 1994-02-01 Isp Investments Inc. Delivery system for agricultural chemicals
US5266590A (en) 1989-12-11 1993-11-30 Isp Investments Inc. Cold stabilization of aqueous microemulsions of a water-insoluble agriculturally active compound
US5110606A (en) 1990-11-13 1992-05-05 Affinity Biotech, Inc. Non-aqueous microemulsions for drug delivery
EP0574492B1 (en) 1991-02-12 1999-05-12 Isp Investments Inc. Stabilization of microemulsions using hydrophobic acid buffers
US5300529A (en) 1991-02-12 1994-04-05 Isp Investments Inc. Stable, clear, efficacious aqueous microemulsion compositions containing a high loading of a water-insoluble, agriculturally active chemical
US6022853A (en) * 1991-08-30 2000-02-08 Creative Biomolecules, Inc. Morphogen-enriched dietary composition
GB9225540D0 (en) 1992-12-07 1993-01-27 Ici Plc Cleaning compositions
JPH06293633A (ja) 1993-04-05 1994-10-21 Shin Etsu Chem Co Ltd 水性腸溶性エマルジョンの製造方法
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
GB2278780B (en) 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
FR2710535B1 (fr) 1993-09-30 1995-11-24 Gattefosse Ets Sa Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion.
DE4337041A1 (de) 1993-10-29 1995-05-04 Henkel Kgaa Verfahren zur Herstellung in Öl-in-Wasser-Emulsionen
WO1995022343A1 (en) 1994-02-17 1995-08-24 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
IL129547A (en) 1994-10-26 2001-01-11 Novartis Ag Pharmaceutical compositions comprising a macrolide and an acid
US5691289A (en) 1994-11-17 1997-11-25 Kay Chemical Company Cleaning compositions and methods of using the same
HU215966B (hu) 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
JPH11505257A (ja) 1995-05-19 1999-05-18 アボツト・ラボラトリーズ 親油性薬物の自己乳化性製剤
SE9503143D0 (sv) 1995-09-12 1995-09-12 Astra Ab New preparation
DE19537836A1 (de) 1995-10-11 1997-04-17 Henkel Kgaa Aerosolemulsionen
KR970064620A (ko) 1996-03-05 1997-10-13 임성기 사이클로스포린-함유 외용약제 조성물
DE19615271A1 (de) 1996-04-18 1997-10-23 Huels Chemische Werke Ag Tensidhaltige Reinigungsmittel in Form einer Mikroemulsion
KR980008239A (ko) 1996-07-26 1998-04-30 김충환 사이클로스포린-함유 약학적 조성물
SK285019B6 (sk) * 1997-01-30 2006-04-06 Novartis Ag Tvrdá želatínová tobolka
NZ337316A (en) * 1997-03-12 2001-06-29 Abbott Lab Hydrophilic binary systems comprising cyclosporine, hydrophilic phase and a surfactant for the administration of cyclosporine
CA2283780A1 (en) 1997-03-12 1998-09-17 Abbott Laboratories Lipophilic binary systems for the administration of lipophilic compounds
US6063762A (en) 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
US6028067A (en) 1997-12-05 2000-02-22 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
WO1999029335A1 (en) 1997-12-05 1999-06-17 Chong Kun Dang Corp. Pharmaceutical composition containing cyclosporin
WO1999029316A1 (en) 1997-12-10 1999-06-17 Severson, Mary, L. Pharmaceutical compositions containing an omega-3 fatty acid oil
NZ329929A (en) * 1998-03-09 1999-10-28 Bernard Charles Sherman Pharmaceutical emulsion preconcentrate containing cyclosporin in a solvent system containing glycerides, propylene or polyethylene glycol, a surfactant and a co-surfactant
ATE404172T1 (de) * 1998-12-30 2008-08-15 Dexcel Ltd Dispergierbares konzentrat zur verabreichung von cyclosporin
GB9912476D0 (en) * 1999-05-28 1999-07-28 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
US6767555B2 (en) 2004-07-27
JP2003500454A (ja) 2003-01-07
AU765935B2 (en) 2003-10-02
NO20015785L (no) 2002-01-23
ZA200109658B (en) 2002-08-20
CN1353613A (zh) 2002-06-12
HUP0201372A2 (en) 2002-09-28
EP1181035B1 (en) 2005-03-30
HK1045642B (en) 2005-10-28
KR20010111587A (ko) 2001-12-19
NO20015785D0 (no) 2001-11-27
GB0128277D0 (en) 2002-01-16
BR0011030A (pt) 2002-02-26
DE60019100T2 (de) 2006-03-23
HUP0201372A3 (en) 2002-10-28
TR200103276T2 (tr) 2002-05-21
RU2249461C2 (ru) 2005-04-10
SK285471B6 (sk) 2007-02-01
AU5810000A (en) 2000-12-18
GB2367004A (en) 2002-03-27
WO2000072867A3 (en) 2001-04-05
EP1181035A2 (en) 2002-02-27
HK1045642A1 (en) 2002-12-06
ES2239605T3 (es) 2005-10-01
US20020188134A1 (en) 2002-12-12
NZ515154A (en) 2003-08-29
IL146186A0 (en) 2002-07-25
DE10084671T1 (de) 2002-06-06
US20020068083A1 (en) 2002-06-06
ATE291926T1 (de) 2005-04-15
PT1181035E (pt) 2005-08-31
MXPA01012222A (es) 2002-07-02
CA2371247A1 (en) 2000-12-07
PL199591B1 (pl) 2008-10-31
PL351593A1 (en) 2003-05-05
DE60019100D1 (de) 2005-05-04
WO2000072867A2 (en) 2000-12-07
SK17222001A3 (sk) 2002-03-05
CZ20014214A3 (cs) 2002-03-13
GB2367004B (en) 2004-04-14
US6432445B1 (en) 2002-08-13

Similar Documents

Publication Publication Date Title
GB9912476D0 (en) Organic compounds
MXPA01009505A (es) Referenciacion portadora modulada por variacion de permeabilidad.
MXPA00007681A (es) Composiciones de epotilona.
ZA97343B (en) Improved compositions containing organic compounds.
ZA200005329B (en) Organic Articles.
GB2354022B (en) Carrier assembly
ZA200006733B (en) Compositions comprising organic mono- or dinitrate for treating impotence.
GB9918429D0 (en) Organic compounds
AP2001002220A0 (en) Calcilytic compounds.
ZA979898B (en) Organic compositions.
GB9812832D0 (en) Improved carrier
GB9926920D0 (en) An information carrier
GB0016825D0 (en) Information carrier
AU6330000A (en) Information carrier
TW459775U (en) Substrate carrier
AU2001225628A1 (en) Information carrier arrangement
ZA99434B (en) Organic compounds.
ZA991789B (en) Organic compounds.
JO2054B1 (en) Zubaydah bath
MY133819A (en) Benzothiophenes, formulations containing same, and methods
ITMO990030V0 (it) Supporto magnetico per apparecchi e attrezzi portatili, ad esempio app arecchi telefonici portatili.
PL109670U1 (en) Carrier
AU140511S (en) Retainer
GB9929289D0 (en) Retainer
AUPR078700A0 (en) Carrier for spores

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)